87 related articles for article (PubMed ID: 30085479)
1. EFFECT OF CARBAMAZEPINE ON THE ACTIVITY OF CYP3A4 ISOENZYME IN PATIENTS WITH ALCOHOL ADDICTION.
Zastrozhin MS; Simirnov VV; Sychev DA; Savchenko LM; Bryun EA; Gushchina YS; Matis OA; Nechaev MO; Naumova AG
Eksp Klin Farmakol; 2016; 79(10):18-21. PubMed ID: 30085479
[TBL] [Abstract][Full Text] [Related]
2. CYP3A4 activity and haloperidol effects in alcohol addicts.
Zastrozhin MS; Smirnov VV; Sychev DA; Savchenko LM; Bryun EA; Matis OA
Int J Risk Saf Med; 2015; 27 Suppl 1():S23-4. PubMed ID: 26639694
[TBL] [Abstract][Full Text] [Related]
3. Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
Zastrozhin MS; Skryabin VY; Smirnov VV; Petukhov AE; Pankratenko EP; Zastrozhina AK; Grishina EA; Ryzhikova KA; Bure IV; Golovinskii PA; Koporov SG; Bryun EA; Sychev DA
Gene; 2020 May; 739():144513. PubMed ID: 32112986
[TBL] [Abstract][Full Text] [Related]
4. [Study on phenotypical activity of isoenzyme CYP3A4 in children].
Kantemirova BI; Chernysheva AKh; Starodubtsev AK; Sychev DA
Antibiot Khimioter; 2012; 57(1-2):23-5. PubMed ID: 22741198
[TBL] [Abstract][Full Text] [Related]
5. The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction.
Sychev DA; Zastrozhin MS; Smirnov VV; Grishina EA; Savchenko LM; Bryun EA
Pharmgenomics Pers Med; 2016; 9():89-95. PubMed ID: 27695358
[TBL] [Abstract][Full Text] [Related]
6. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
Bedada SK; Appani R; Boga PK
Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
[TBL] [Abstract][Full Text] [Related]
7. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.
Grimm SW; Richtand NM; Winter HR; Stams KR; Reele SB
Br J Clin Pharmacol; 2006 Jan; 61(1):58-69. PubMed ID: 16390352
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the potential for pharmacokinetic drug-drug interaction between armodafinil and carbamazepine in healthy adults.
Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P
Clin Ther; 2015 Feb; 37(2):325-37. PubMed ID: 25438721
[TBL] [Abstract][Full Text] [Related]
9. Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.
Sychev DA; Zastrozhin MS; Miroshnichenko II; Baymeeva NV; Smirnov VV; Grishina EA; Ryzhikova KA; Mirzaev KB; Markov DD; Skryabin VY; Snalina NE; Nosikova PG; Savchenko LM; Bryun EA
Drug Metab Pers Ther; 2017 Sep; 32(3):129-136. PubMed ID: 28787271
[TBL] [Abstract][Full Text] [Related]
10. High Doses of Drugs Extensively Metabolized by CYP3A4 Were Needed to Reach Therapeutic Concentrations in Two Patients Taking Inducers.
Chopra N; Ruan CJ; McCollum B; Ognibene J; Shelton C; de Leon J
Rev Colomb Psiquiatr (Engl Ed); 2020; 49(2):84-95. PubMed ID: 32446424
[TBL] [Abstract][Full Text] [Related]
11. Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy.
Wide K; Larsson H; Bertilsson L; Diczfalusy U
Br J Clin Pharmacol; 2008 May; 65(5):708-15. PubMed ID: 18279471
[TBL] [Abstract][Full Text] [Related]
12. The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction.
Zastrozhin MS; Grishina EA; Ryzhikova KA; Smirnov VV; Savchenko LM; Bryun EA; Sychev DA
Pharmgenomics Pers Med; 2018; 11():1-5. PubMed ID: 29343979
[TBL] [Abstract][Full Text] [Related]
13. [Risk of pharmacological interactions due to the co-administration of statins and cytochrome P450 isoenzyme 3A4-metabolized drugs: multicentre, crossover study].
Mostaza JM; Lahoz C; Morales-Olivas F; Pinto X; Tranche S; Suarez-Tembra M; Mantilla T; Rius J
Med Clin (Barc); 2014 Nov; 143(10):427-32. PubMed ID: 24216013
[TBL] [Abstract][Full Text] [Related]
14. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers.
Shahzadi A; Javed I; Aslam B; Muhammad F; Asi MR; Ashraf MY; Zia-ur-Rahman
Pak J Pharm Sci; 2011 Jan; 24(1):63-8. PubMed ID: 21190921
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS
Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127
[TBL] [Abstract][Full Text] [Related]
17. Reduction of nevirapine-driven HIV mutations by carbamazepine is modulated by CYP3A activity.
Baranyai D; Muro E; Gödtel-Armbrust U; Schirmer MA; Kisanga E; Diczfalusy U; Fillekes Q; Schuurman R; Burger D; Wojnowski L
J Antimicrob Chemother; 2014 Jul; 69(7):1933-7. PubMed ID: 24695353
[TBL] [Abstract][Full Text] [Related]
18. CYP3A subfamily activity affects the equilibrium concentration of Phenazepam
Zastrozhin MS; Skryabin VY; Sorokin AS; Petukhov AE; Smirnov VV; Pankratenko EP; Grishina EA; Ryzhikova KA; Panov AS; Savchenko LM; Bryun EA; Sychev DA
Pharmacogenomics; 2020 May; 21(7):449-457. PubMed ID: 32336193
[TBL] [Abstract][Full Text] [Related]
19. Urinary 6beta-hydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction.
Konishi H; Tanaka K; Minouchi T; Yamaji A
Ann Clin Biochem; 2004 Jul; 41(Pt 4):335-7. PubMed ID: 15298747
[TBL] [Abstract][Full Text] [Related]
20. Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism.
Sanchez Spitman AB; Moes DJAR; Gelderblom H; Dezentje VO; Swen JJ; Guchelaar HJ
Eur J Clin Pharmacol; 2017 Dec; 73(12):1589-1598. PubMed ID: 28849250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
